Trials / Completed
CompletedNCT01147224
ATEM (Alvesco Non-interventional Study)
Alvesco for the Therapy of Persistent Asthma With or Without Allergic Component
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the efficacy of Alvesco in patients with persistent asthma including or excluding allergic components over 3 months, especially in the spring season. Alvesco will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of Alvesco .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alvesco | This is an observational study. Therefore, the physician decides about dosage according to individual needs. |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-05-01
- Completion
- 2011-08-01
- First posted
- 2010-06-22
- Last updated
- 2016-12-05
Locations
79 sites across 1 country: Austria
Source: ClinicalTrials.gov record NCT01147224. Inclusion in this directory is not an endorsement.